Virbac: Availability of the half-yearly financial report as of June 30, 2018
Virbac: Availability of the half-yearly financial report as of June 30, 2018
Public release - September 17, 2018
Virbac announced today that the 2018 half-yearly financial report is now available and has been filed with the French financial markets authority (AMF - Autorités des marchés financiers).
The half-yearly financial report is available:
· on our website: corporate.virbac.com under the section Investors - Financial reports - 2018,
· or on request, under legal and regulatory conditions.
In accordance with the terms implemented by the French financial markets authority (AMF), this document presents:
· the 2018 half-yearly management report,
· the condensed consolidated financial statements at June 30, 2018,
· the statutory auditors' review report on the 2018 half-yearly financial information,
· the statement of responsibility for the half-yearly financial report.
Virbac: NYSE Euronext - compartment B - ISIN code: FR0000031577/SYMBOL: VIRP
Corporate finance: +33 4 92 08 71 32 - finances@virbac.com - corporate.virbac.com
Attachment
Upcoming Life Sciences Events
- April 2024
- Pharma-Biotech Product & Company Valuation - An Introductory
- Basel: Swiss Biotech Day 2024
- London: BioTrinity 2024